Rentokil Initial leverages massive global scale to dominate essential pest control and hygiene markets.
Integration of the Terminix acquisition continues to create operational friction and legal expenses.
A homeowner notices a trail of ants marching through the pantry and calls the one company that local businesses and residents rely on to make the problem disappear. That company is Rentokil Initial (NYSE:RTO), the world's largest provider of pest control and hygiene services. It operates a vast, route-based network across roughly 90 countries, effectively turning the essential but invisible task of maintaining sanitary environments into a massive, recurring-revenue business. Currently priced at $19.86 as of Oct. 7, 2026, the stock has declined 29% over the past year as the market weighs the operational friction of its global consolidation against the stability of its core model.
Our proprietary Hidden Gems scoring system assigns Rentokil Initial an overall Superscore of 72 out of 100, placing it in the Above Average category. The Superscore is an AI-powered score that evaluates a company's overall strength by combining financial performance, product market position, technological capabilities, leadership quality, and relative valuation. It represents the unification of all our scores into a single score for public companies, with five rating bands: Exceptional (90-100), Strong (75-89), Above Average (60-74), Average (40-59), and Cautious (0-39).
A 72 Superscore places Rentokil Initial in the top ~26% of every company we score. This score serves as one data-driven research input, and this article balances the reasons for its strength against the risks that keep it from ranking higher, so you can weigh both sides.
| Score | Score (out of 100) | Rank | Supporting Data Point |
|---|---|---|---|
| Product (1Y) | 52 | Bottom ~45% | Integration challenges in North America have hampered growth and profitability, creating operational friction. |
| Product (5Y) | 65 | Top ~37% | The 5-year outlook is bolstered by the 2022 Terminix acquisition which cemented global leadership in a recurring-revenue industry. |
| Financial (1Y) | 81 | Top ~12% | Revenue growth of 4% in 2025 shows successful scaling and improved working capital management. |
| Financial (5Y) | 67 | Top ~31% | Aggressive inorganic growth led to fluctuating margins and debt-funded capital intensity. |
| Leaders | 70 | Top ~44% | Management is transparent about commercial underperformance and has implemented a clear back-to-basics operational roadmap. |
| AI | 18 | Bottom ~22% | The business is anchored in manual labor and lacks proprietary data assets for external monetization or agentic AI integration. |
| Valuation Risk | 64 | Top ~33% | The trailing P/E of 21 reflects premium market expectations that leave little room for error if growth targets slip. |
This stock warrants a closer look if...
You may want to keep researching before buying if...
The Superscore provides a data-driven signal, but it is not a buy recommendation; you should weigh these strengths and risks against your own research and risk tolerance.
Rentokil's single-digit growth rate over the past year has weighed on the stock. The shares are not cheap, trading at a P/E of 21, but that multiple implies growth expectations that haven't been met in recent quarters. Assuming the company can accelerate its top-line growth with operational adjustments, the stock has the potential to at least double in the next five years.
Still, this is a business in transition, with the promise of better days ahead that the current valuation may not reflect. Management is simplifying the business structure to improve leads and sales.
The company has excellent reach globally, giving it a competitive advantage in the pest control market. By focusing more resources on high-growth markets and leveraging its scale, the business could see improved growth and margin rates.
Even with execution issues, revenue grew 4.5% year over year in the second quarter, while operating profit rose 6.6%. The stock is trading at just 13 times forward earnings estimates, suggesting significant upside if recent business issues are resolved.
The Hidden Gems Superscore reflects The Motley Fool's proprietary AI-driven evaluation of a company across product, financial, leadership, and valuation pillars as of the article date and may change over time. Performance figures are point-in-time. Past performance does not guarantee future results.
Before you buy stock in Rentokil Initial Plc, consider this:
The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Rentokil Initial Plc wasn’t one of them. The 10 stocks that made the cut could produce monster returns in the coming years.
Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you’d have $370,440!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you’d have $1,470,022!*
Now, it’s worth noting Stock Advisor’s total average return is 955% — a market-crushing outperformance compared to 215% for the S&P 500. Don't miss the latest top 10 list, available with Stock Advisor, and join an investing community built by individual investors for individual investors.
See the 10 stocks »
*Stock Advisor returns as of October 8, 2026.
John Ballard has no position in any of the stocks mentioned. The Motley Fool recommends Rentokil Initial Plc. The Motley Fool has a disclosure policy.